Back
Stoke Therapeutics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
9
STOK
Stoke Therapeutics
Last Price:
$6.43
Seasonality Move:
-2.4%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.36 | Sell |
20-day SMA: | 7.48 | Sell |
50-day SMA: | 8.85 | Sell |
200-day SMA: | 11.94 | Sell |
8-day EMA: | 6.4 | Sell |
20-day EMA: | 7.19 | Sell |
50-day EMA: | 8.43 | Sell |
200-day EMA: | 10.53 | Sell |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.79 | Sell |
Relative Strength Index (14 RSI): | 28.89 | Sell |
Chaikin Money Flow: | -461084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Stoke Therapeutics Technical Analysis
Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 5.90 while STOK 8-day simple moving average is 6.36, which is a Sell signal.
-
The stock price of STOK is 5.90 while Stoke Therapeutics 20-day SMA is 7.48, which makes it a Sell.
-
Stoke Therapeutics 50-day simple moving average is 8.85 while STOK share price is 5.90, making it a Sell technically.
-
STOK stock price is 5.90 and Stoke Therapeutics 200-day simple moving average is 11.94, creating a Sell signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
9
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a SellThe current Stoke Therapeutics [STOK] share price is $5.90. The Score for STOK is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
319.1M
Price in USD:
5.90
Share Volume:
1.2M
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
5.45
Sell
9
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?The Stoke Therapeutics stock price is 5.90 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 5.90 while STOK 8-day exponential moving average is 6.40, which is a Sell signal.
-
The stock price of STOK is 5.90 while Stoke Therapeutics 20-day EMA is 7.19, which makes it a Sell.
-
Stoke Therapeutics 50-day exponential moving average is 8.43 while STOK share price is 5.90, making it a Sell technically.
-
STOK stock price is 5.90 and Stoke Therapeutics 200-day simple moving average is 10.53, creating a Sell signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and a decrease next year of $0.84 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is -0.79, suggesting Stoke Therapeutics is a Sell
-
Stoke Therapeutics Relative Strength Index (RSI) is 28.89, which suggest Stoke Therapeutics is oversold
-
The Bollinger Bands (25) for Stoke Therapeutics is ( - ), which suggest Stoke Therapeutics is a Buy
-
The Bollinger Bands (100) for Stoke Therapeutics is ( - ), which suggest Stoke Therapeutics is a Buy
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.